OPFOLDA 65 MG Oral Capsule
- RxCUI
- 2667432
- RxNorm name
- OPFOLDA 65 MG Oral Capsule
- Display name
- OPFOLDA 65 MG Oral Capsule
- Full name
- OPFOLDA 65 MG Oral Capsule
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:23
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OPFOLDA | MIGLUSTAT | AMICUS THERAPEUTICS US, LLC | d7c38298-37db-5a80-e053-2995a90aee40 | 2024-11-27 | Warnings, Adverse reactions | 2667432 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| d7c38298-37db-5a80-e053-2995a90aee40 | OPFOLDA 65 MG Oral Capsule | PSN | 5 | These highlights do not include all the information needed to use OPFOLDA ® safely and effectively. See full prescribing information for OPFOLDA. OPFOLDA (miglustat) capsules, for oral use Initial U.S. Approval: 2003 | 20241127 |
| d7c38298-37db-5a80-e053-2995a90aee40 | miglustat 65 MG Oral Capsule [Opfolda] | SBD | 5 | These highlights do not include all the information needed to use OPFOLDA ® safely and effectively. See full prescribing information for OPFOLDA. OPFOLDA (miglustat) capsules, for oral use Initial U.S. Approval: 2003 | 20241127 |
| d7c38298-37db-5a80-e053-2995a90aee40 | Opfolda 65 MG Oral Capsule | SY | 5 | These highlights do not include all the information needed to use OPFOLDA ® safely and effectively. See full prescribing information for OPFOLDA. OPFOLDA (miglustat) capsules, for oral use Initial U.S. Approval: 2003 | 20241127 |